Biomarker strategy for enrichment and monitoring of biological effect in ACCTION, a phase II study of ACC-001 (vanutide cridificar) for Alzheimer's diseaseRichard Margolin,Nzeera Ketter,Spencer Guthrie,Denise Deegan,Linda Baher, Renee Tschopp,Kenneth Marek,John Seibyl,Gerald Novak,Johannes Streffer,Chahin Pachai,Bradley T. Wyman,Kevin Booth,Eric C. Yuen,Daniel Gennevois,Enchi LiuAlzheimers & Dementia（2013）引用 1|浏览21暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
